Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026
Rhea-AI Summary
Integra LifeSciences (NASDAQ: IART) will release fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, prior to market open. Management will host a conference call at 8:30 a.m. ET with a live webcast on the company Investor site.
Investors can register to receive dial-in details and a PIN; joining 10 minutes early is recommended. A webcast replay will be posted on the Investors section following the call.
Positive
- None.
Negative
- None.
News Market Reaction – IART
On the day this news was published, IART declined 2.93%, reflecting a moderate negative market reaction. Argus tracked a trough of -6.0% from its starting point during tracking. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $26M from the company's valuation, bringing the market cap to $877.07M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
IART was up 3.49% while peers showed mixed moves: several (e.g., AHCO, ESTA, INMD) were positive and BBNX was negative, and no peers appeared in the momentum scanner, suggesting a stock-specific move rather than a confirmed sector-wide rotation.
Previous Conferences,earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| 2025-10-15 | Earnings call scheduling | Neutral | -1.2% | Announcement of Q3 2025 results release and earnings call timing. |
| 2025-07-14 | Earnings call scheduling | Neutral | -3.9% | Scheduling notice for Q2 2025 results and investor conference call. |
| 2025-04-18 | Earnings call scheduling | Neutral | -4.0% | Announcement of Q1 2025 results date and related conference call. |
| 2025-02-04 | Earnings call scheduling | Neutral | +0.2% | Notice of Q4 and full-year 2024 results release and call timing. |
| 2024-10-14 | Earnings call scheduling | Neutral | -0.1% | Scheduling of Q3 2024 financial results announcement and webcast. |
Earnings call scheduling headlines with tag "conferences,earnings" have historically led to modest moves, averaging about -1.79% over 5 prior events, with a slight negative bias but no large reactions.
Recent tagged events show a consistent pattern of Integra announcing quarterly earnings calls ahead of results dates. Over 2024–2025, five "conferences,earnings" notices outlined release dates and 8:30 a.m. ET calls, typically before market open. Price reactions to these scheduling updates have been small, with individual moves ranging from about -4% to near flat. The upcoming fourth quarter and full-year 2025 call fits this established communication cadence ahead of detailed financial disclosures.
Historical Comparison
In the past year, Integra issued 5 similar conferences/earnings call notices, with an average move of -1.79%. The current pre-call gain of 3.49% is more positive than those prior reactions.
The company has maintained a steady pattern of quarterly earnings call announcements from late 2024 through 2025, covering Q3 2024 through Q3 2025 and now moving to Q4 and full-year 2025 results.
Market Pulse Summary
This announcement outlines the timing of Integra’s fourth quarter and full-year 2025 earnings release and conference call on February 26, 2026 at 8:30 a.m. ET. Similar conferences/earnings notices over the past year have produced only modest price moves, with an average reaction near -1.79%. Investors tracking the story may focus on the forthcoming details on revenue, profitability, and guidance, comparing them to prior quarterly trends and any recent strategic or regulatory developments.
AI-generated analysis. Not financial advice.
PRINCETON, N.J., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.
A live webcast will be available on the Investors section of the Company’s website at investor.integralife.com. For those planning to participate on the call, register here to receive dial-in details and an individual pin. While not required, joining 10 minutes before the event starts is recommended. A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call.
About Integra LifeSciences
Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard products and solutions is trusted by healthcare professionals to improve patient outcomes. For the latest news and information about Integra and its products, please visit www.integralife.com.
Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com
Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com
Integra LifeSciences Holdings Corporation
FAQ
When will Integra LifeSciences (IART) report Q4 and full year 2025 results?
What time is the Integra (IART) earnings conference call on February 26, 2026?
How can investors access the Integra (IART) earnings webcast and replay?
Do I need to register to join the Integra (IART) earnings call on February 26, 2026?
Will Integra (IART) provide a replay of the February 26, 2026 earnings call?
